Different findings support the involvement of the serotonin (5-HT) system in panic disorder. The presence of the 5-HT transporter in blood platelets similar to that in presynaptic serotonergic neurons, permits the investigation of this structure in periphery., We therefore evaluated the binding of H-3-paroxetine, a selective 5-HT reuptake inhibitor which is considered the ligand of choice for labelling the 5-HT transporter, in platelets of 20 drug-flee patients with panic disorder. The same measurement was repeated after one year's treatment with different drugs. The results showed patients to have-a lower number of H-3-paroxetine sites than a group of age- and sex-matched controls, thus suggesting the involvement of the 5-HT transporter in panic disorder. This abnormality reverted after one year of treatment with specific drugs that provoked the symptom remission in all cases, which would suggest a link with the clinical improvement.

Decreased platelet H-3-paroxetine binding in untreated panic disorder patients

ROSSI, ALESSANDRA;DELL'OSSO, LILIANA;PALEGO, LIONELLA;GIANNACCINI, GINO;LUCACCHINI, ANTONIO;
1999

Abstract

Different findings support the involvement of the serotonin (5-HT) system in panic disorder. The presence of the 5-HT transporter in blood platelets similar to that in presynaptic serotonergic neurons, permits the investigation of this structure in periphery., We therefore evaluated the binding of H-3-paroxetine, a selective 5-HT reuptake inhibitor which is considered the ligand of choice for labelling the 5-HT transporter, in platelets of 20 drug-flee patients with panic disorder. The same measurement was repeated after one year's treatment with different drugs. The results showed patients to have-a lower number of H-3-paroxetine sites than a group of age- and sex-matched controls, thus suggesting the involvement of the 5-HT transporter in panic disorder. This abnormality reverted after one year of treatment with specific drugs that provoked the symptom remission in all cases, which would suggest a link with the clinical improvement.
Marazziti, D; Rossi, Alessandra; Dell'Osso, Liliana; Palego, Lionella; Placidi, Gpa; Giannaccini, Gino; Lucacchini, Antonio; Cassano, Gb
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/199931
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 21
social impact